Biden adds weight loss drugs to Medicare price negotiations
Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.
Medicare to negotiate for Ozempic
Popular but pricey weight-loss drugs Ozempic and Wegovy are among the 15 medications whose prices will be subject to direct negotiations between Medicare and drug makers.
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...
NJBIZ2 天
Wegovy, Ozempic targeted for Medicare price negotiations (updated)
The U.S. Centers for Medicare and Medicaid Services released its list of drugs covered under Medicare Part D selected for the ...
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...
Fox 92 天
Feds target Ozempic, Wegovy for lower Medicare prices
Ozempic and Wegovy are among the 15 drugs added to Medicare's list of medications that will be negotiated for lower prices. This is part of an effort to lower prescription drug prices for Medicare ...
MM&M3 天
Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Pharm Exec3 天
HHS Selects 15 New Drugs for Medicare Part D Price Negotiations
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...
Biden Is Targeting These 15 Drugs For Medicare Price Negotiations
The Biden administration has selected the next 15 drugs for Medicare drug price negotiations. The drugs treat conditions such ...